Live tape
Top 8, mentions 7d18,251MSFT3,395 mentions▲ +0.09AAPL2,656 mentions▲ +0.07GOOGL2,632 mentions▲ +0.05META2,224 mentions▲ +0.04SNDK2,157 mentions▲ +0.06NVDA1,837 mentions▲ +0.07SPCX1,707 mentions▲ +0.06AMZN1,643 mentions▲ +0.10

Equity · Healthcare

BLLN

BillionToOne, Inc. · NasdaqGS

$138.57 −1.03% 1D Finazon · prior-day close · Jul 31, 2026
Price · Chart Chart by TradingView

The chart above plots the price of BLLN over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 63 sessions over that window: $72.00 on 4 May 2026 through $138.57 on 31 July 2026. Finazon · prior-day close.

Market cap $7.3B
52-week range $64.00 – $140.00
Avg volume 169.2K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 2, 2026

BLLN insider trades

SEC Form 4 · last 90 days · newest reported trade 16 Jul 2026
Open-market buys 0
Open-market sells 15
Net sold $18.65M
Non-trade filings 13
Date Insider Type Shares Value
16 Jul 2026 Johnson Nancy JoAnn See Remarks Sell 14,199 $1.82M
13 Jul 2026 ten Bosch John Roderick SVP of Laboratory Operations Sell 1,417 $178K
13 Jul 2026 Tsao David Chief Technology Officer Sell 20,000 $2.50M
09 Jul 2026 Atay Oguzhan Chairman and CEO Sell 12,500 $1.58M
09 Jul 2026 Sakakibara Shan Riku Chief Product Officer Sell 8,000 $1.00M
06 Jul 2026 Atay Oguzhan Chairman and CEO Sell 35,410 $4.32M
01 Jul 2026 Johnson Nancy JoAnn See Remarks Sell 801 $100K
29 Jun 2026 ten Bosch John Roderick SVP of Laboratory Operations Sell 1,416 $170K
24 Jun 2026 Sakakibara Shan Riku Chief Product Officer Sell 4,000 $440K
15 Jun 2026 ten Bosch John Roderick See Remarks Sell 1,416 $144K
15 Jun 2026 Tsao David Chief Technology Officer Sell 20,000 $2.05M
09 Jun 2026 Johnson Nancy JoAnn See Remarks Sell 10,582 $1.06M

Showing the 12 most recent of 15 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
13 Jul 2026 Tsao David Chief Technology Officer Option exercise 10,000 $28K
09 Jul 2026 Atay Oguzhan Chairman and CEO Option exercise 12,500 $35K
09 Jul 2026 Sakakibara Shan Riku Chief Product Officer Option exercise 4,000 $119K
06 Jul 2026 Atay Oguzhan Chairman and CEO Option exercise 26,250 $74K
24 Jun 2026 Sakakibara Shan Riku Chief Product Officer Option exercise 4,000 $35K
15 Jun 2026 Tsao David Chief Technology Officer Option exercise 10,000 $28K
10 Jun 2026 KOLLURI KRISHNA KITTU Director Award 3,017
10 Jun 2026 Rai Akshay Director Award 3,017
10 Jun 2026 Ileri Firat Director Award 3,017
10 Jun 2026 Pagano Anthony Director Award 3,017
09 Jun 2026 Atay Oguzhan See Remarks Gift 10,000
08 Jun 2026 Atay Oguzhan See Remarks Option exercise 26,250 $74K

Showing the 12 most recent of 13 compensation filings in this window. The figures above count all of them.

BLLN reported financials

SEC EDGAR XBRL

BLLN reported revenue of $305.1M for the fiscal year ended 31 Dec 2025. Net income over the same period was $7.5M.

Figure Reported Period
Revenue $305.1M 31 Dec 2025 fiscal year
Net income $7.5M 31 Dec 2025 fiscal year
Diluted EPS $0.14 31 Dec 2025 fiscal year
Total assets $700.7M 31 Mar 2026 at period end
Total equity $505.6M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

BLLN earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.34 $108M
31 Dec 2025 FY 2025 $0.14 $305M
30 Sep 2025 Q3 2025 $0.10 $84M
31 Mar 2025 Q1 2026 $-0.39 $59M
31 Dec 2024 FY 2025 $-4.12 $153M
30 Sep 2024 Q3 2025 $-1.47 $38M
31 Dec 2023 FY 2025 $-8.45 $72M

Reported figures & scheduled dates · SEC EDGAR filings

BLLN institutional holders

SEC Form 13F

4 of the 45 institutional funds we track reported a BLLN position for the quarter ended 31 Mar 2026 — a combined $12.0M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Two Sigma Investments New position 82,776 $6.5M
Renaissance Technologies New position 51,254 $4.0M
Soros Fund Management Held (±25%) 14,500 $1.1M
D. E. Shaw & Co. New position 3,862 $305K
Marshall Wace Exited

Source: SEC EDGAR 13F filings

BLLN fails-to-deliver

SEC CNS data

On 09 Jul 2026, 9,599 shares of BLLN failed to deliver (about $1.2M) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
09 Jul 2026 9,599 $1.2M 0.018%
08 Jul 2026 3,481 $411K 0.007%
29 Jun 2026 28,168 $3.3M 0.053%
26 Jun 2026 2,778 $312K 0.005%
25 Jun 2026 66 $7K <0.001%
24 Jun 2026 1,816 $189K 0.003%
23 Jun 2026 22,461 $2.3M 0.042%
22 Jun 2026 6,887 $724K 0.013%

Source: SEC fails-to-deliver (CNS) data